Measurement of patient compliance

Pharmacy World and Science

Volumn 20, Issue 2, 1998, Pages 73-77

  Paes, A H P ^a   Bakker, A ^a   Soe Agnie, C J ^b  

^a UTRECHT UNIVERSITY   (Netherlands)

^b Centrum Apotheek   (Netherlands)

Author keywords

Data collection; Oral antidiabetics; Patient compliance

Indexed keywords

ORAL ANTIDIABETIC AGENT;

ADULT; AGED; ARTICLE; DIABETES MELLITUS; DRUG MONITORING; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PATIENT COMPLIANCE; PATIENT MONITORING; PHARMACY; PRESCRIPTION; QUESTIONNAIRE;

ADULT; AGED; DIABETES MELLITUS; HUMANS; HYPOGLYCEMIC AGENTS; MIDDLE AGED; MONITORING, PHYSIOLOGIC; PATIENT COMPLIANCE; PHARMACY; PRESCRIPTIONS, DRUG; RECORDS; TABLETS;

EID: 0031971463     PISSN: 09281231     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008663215166     Document Type: Article

References (18)

1. Backes JM, Schentag JJ. Partial compliance as a source of variance in pharmacokinetics and therapeutic drug monitoring. In: Cramer JA, Spilker B, eds. Patient compliance in medical practice and clinical trials. New York: Raven Press, 1991: 27-36.
2. Levy RA. Failure to refill prescriptions. In: Cramer JA, Spilker B, eds. Patient compliance in medical practice and clinical trials. New York: Raven Press, 1991: 11-8.
3. Blom AThG, Paes AHP. De therapie-trouw kan worden verbeterd (Patient compliance can be improved). Geneesmiddelenbulletin 1992;26: 40-3.
4. Mikael RL, Sharpe T. Patient compliance. In: Wertheimer AI, Smith MC, eds. Pharmacy practice. Baltimore: University Park Press, 1974: 179-94.
5. Cramer JA, Mattson RH, Prevey ML, Scheyer RD, Ouellette VL. How often is medication taken as prescribed? A novel assessment technique. JAMA 1989;261: 3273-7.
6. Epstein LH, Cluss PA. A behavioral medicine perspective on adherence to longterm medical regimens. J Consult Clin Psychol 1982;50: 950-71.
7. Pennings-van der Eerden L, Visser APh. Diabetes mellitus. In: Kaptein AA, van der Ploeg HM, Garssen B, Schreurs PJG, Beunderman R, eds. Behavioral medicine. Alphen a/d Rijn: Samsom Stafleu, 1986.
8. Stolk RP, Grobbee DE. Epidemiologie van diabetes mellitus (Epidemiology of diabetes mellitus). Diagnose Informatie en Medische Statistiek (DIMS) 1992;(12): 4-7.
9. Herings RMC. Effecten van chronisch/gecombineerd gebruik van geneesmiddelen (Effects of chronic drug use). Utrecht: Vakgroep Praktische Farmacie, 1989.
10. Rudd P, Ahmed S, Zachery V, Barton C, Bonduelle D. Improved compliance measures: Applications in an ambulatory hypertensive drug dial. Clin Pharmacol Ther 1990;48: 676-85.
11. Waterhouse DM, Calzone KA, Mele C, Brenner DE. Adherence to oral tamoxifen: A comparison of patient self-report, pill counts, and microelectronic monitoring. Eur J Clin Pharm 1993;11: 1189-97.
12. Kruse W, Nikolaus T, Rampmaier J, Weber E, Schliert G. Actual versus prescribed timing of lovastatin doses assessed by electronic compliance monitoring. Eur J Clin Pharm 1993;45: 211-5.
13. De Tullio PL, Kirking DM, Arslanian C, Olson DE. Compliance measure development and assessment of theophylline therapy in ambulatory patients. J Clin Pharm Ther 1987;12:19-26.
14. Enlund H, Tuomilehto J, Turakka H. Patient report validated against prescription records for measuring use of and compliance with antihypertensive drugs. Acta Med Scand 1981;209: 271-5.
15. Dowse R, Futter WT. Outpatient compliance with theophyl-line and phenytoin therapy. S Afr Med J 1991;80: 550-3.
16. Inui ThS, Carter WB, Pecoraro RE. Screening for noncompliance among patients with hypertension: Is self-report the best available measure? Med Care 1981;19: 1061-4.
17. Sackett DL. A compliance practicum for the busy practitioner. In: Haynes RB, Taylor DW, Sacket DL, eds. Compliance in health care. Baltimore: The Johns Hopkins University Press, 1979: 290.
18. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986;24: 67-74.